730,000 Filipino Children Receive Faulty Dengue Vaccine Which Causes Dengue Rather Than Preventing it
In a story that is being mostly censored in the U.S. media, vaccine manufacturer Sanofi Pasteur has admitted that their vaccine for dengue (a deadly tropical disease spread mostly by mosquitoes) is defective. In a press release from France, the pharmaceutical company admitted that the vaccine is harmful to those not previously infected with dengue, and could cause children not previously infected with dengue to contract a severe case of the disease. The Philippines was the first country in Asia to approve the vaccine for individuals aged 9 and 45 years old in December 2015. More than 730,000 Filipino children have received at least one dose of Dengvaxia, the first licensed vaccine for the virus, since the Philippine Department of Health launched the vaccination drive in schools last year.